Detalhe da pesquisa
1.
Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity.
Nat Immunol
; 21(7): 756-765, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32572240
2.
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024.
Int Arch Allergy Immunol
; 185(3): 286-300, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38086339
3.
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
Allergy
; 77(11): 3408-3425, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690994
4.
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
Allergy
; 77(1): 230-242, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453317
5.
Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
Allergy
; 76(3): 751-765, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33128792
6.
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4+ T cells resembling iTreg.
Front Immunol
; 14: 1094694, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090735
7.
The making and function of CAR cells.
Immunol Lett
; 212: 53-69, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31181279
8.
Pharmacological targeting of allergen-specific T lymphocytes.
Immunol Lett
; 189: 27-39, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28322861